CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 237 filers reported holding CONMED CORP in Q3 2019. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $406,148 | +75.1% | 4,582 | +58.1% | 0.00% | +50.0% |
Q3 2022 | $232,000 | -91.3% | 2,898 | -89.6% | 0.00% | -92.3% |
Q2 2022 | $2,676,000 | -59.1% | 27,954 | -36.5% | 0.03% | -55.9% |
Q1 2022 | $6,536,000 | -37.6% | 43,999 | -40.5% | 0.06% | -37.9% |
Q4 2021 | $10,482,000 | +655.2% | 73,936 | +632.0% | 0.10% | +533.3% |
Q2 2021 | $1,388,000 | -67.0% | 10,100 | -68.6% | 0.02% | -70.6% |
Q1 2021 | $4,206,000 | +507.8% | 32,213 | +266.1% | 0.05% | +292.3% |
Q3 2020 | $692,000 | -77.2% | 8,800 | -79.1% | 0.01% | -68.3% |
Q2 2020 | $3,034,000 | +147.5% | 42,144 | +96.9% | 0.04% | -46.8% |
Q1 2020 | $1,226,000 | +108.1% | 21,400 | +305.9% | 0.08% | +450.0% |
Q4 2019 | $589,000 | +145.4% | 5,272 | +110.9% | 0.01% | +100.0% |
Q3 2019 | $240,000 | -11.4% | 2,500 | -32.4% | 0.01% | -53.3% |
Q2 2018 | $271,000 | -43.4% | 3,700 | -51.1% | 0.02% | -58.3% |
Q1 2018 | $479,000 | -43.5% | 7,562 | -57.4% | 0.04% | -81.1% |
Q2 2016 | $848,000 | – | 17,770 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |